Published on in Vol 8, No 3 (2022): March
![Use of HIV Recency Assays for HIV Incidence Estimation and Other Surveillance Use Cases: Systematic Review Use of HIV Recency Assays for HIV Incidence Estimation and Other Surveillance Use Cases: Systematic Review](https://asset.jmir.pub/assets/8c1cbf2364f0e018a0f005dd67f6d003.png 480w,https://asset.jmir.pub/assets/8c1cbf2364f0e018a0f005dd67f6d003.png 960w,https://asset.jmir.pub/assets/8c1cbf2364f0e018a0f005dd67f6d003.png 1920w,https://asset.jmir.pub/assets/8c1cbf2364f0e018a0f005dd67f6d003.png 2500w)
1 Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, United States
2 Facente Consulting, Richmond, CA, United States
3 Vitalant Research Institute, San Francisco, CA, United States
4 South African Centre for Epidemiological Modeling and Analysis (SACEMA), Stellenbosch University, Stellenbosch, South Africa
5 Institute for Global Health Sciences, University of California San Francisco, San Francisco, CA, United States
6 Strategic Information Department, The Joint United Nations Programme on HIV/AIDS (UNAIDS), Geneva, Switzerland
7 Global HIV, Hepatitis and Sexually Transmitted Infections Programmes, World Health Organisation, Geneva, Switzerland